SUDO BIOSCIENCES
Sudo Biosciences is a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain, a crucial mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions. Its pipeline of next-generation TYK2 inhibitors includes a potential brain-penetrant candidate for treating multiple sclerosis and neurodegenerative diseases with underlying neuroinflammation and a potential topical candidate for immune-mediated dermatologic diseases. It helps patients receive the cure or the treatment of multiple sclerosis and neurodegenerative diseases with underlying neuroinflammation at a competitive cost.
SUDO BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science Medical
Founded:
2020-01-01
Address:
Carmel, Indiana, United States
Country:
United States
Website Url:
http://www.sudobio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
183 M USD
Technology used in webpage:
Font Awesome Mobile Non Scaleable Content ReCAPTCHA U.S. Server Location Java EE GoDaddy SSL Visa MasterCard American Express
Similar Organizations
MapLight Therapeutics
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
FogPharma
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Current Advisors List
Current Employees Featured
Founder
Investors List
Leaps by Bayer
Leaps by Bayer investment in Series B - Sudo Biosciences
Velosity Capital
Velosity Capital investment in Series B - Sudo Biosciences
Frazier Life Sciences
Frazier Life Sciences investment in Series B - Sudo Biosciences
Dementia Discovery Fund
Dementia Discovery Fund investment in Series B - Sudo Biosciences
UPMC Enterprises
UPMC Enterprises investment in Series B - Sudo Biosciences
Monograph Capital
Monograph Capital investment in Series B - Sudo Biosciences
Surveyor Capital
Surveyor Capital investment in Series B - Sudo Biosciences
Sanofi Ventures
Sanofi Ventures investment in Series B - Sudo Biosciences
TPG
TPG investment in Series B - Sudo Biosciences
Eventide
Eventide investment in Series B - Sudo Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-10-10 | Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer |
Official Site Inspections
http://www.sudobio.com Semrush global rank: 5.59 M Semrush visits lastest month: 1.29 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Sudo Biosciences"
Sudo Biosciences - Crunchbase Company Profile
Contact Email [email protected] Sudo Biosciences is a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain, a crucial mediator in cytokine signaling …See details»
Sudo Biosciences - LinkedIn
Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives.See details»
Sudo Biosciences, Inc. - Drug pipelines, Patents, Clinical trials
Www.sudobio.com. Startups | Holding Company | 2020 | Indiana, United States | 10-50 | www.sudobio.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Sudo Biosciences - Overview, News & Similar companies - ZoomInfo
Oct 15, 2022 Sudo Biosciences has announced that Imran Babar has joined the organization as Chief Business Officer. Previously, Babar served as Chief Business Officer for Cydan. ... Sudo …See details»
Sudo Biosciences Company Profile | Management and Employees …
Www.sudobio.com Sudo Biosciences Profile and History Founded in 2020 and headquartered in Menlo Park, California, Sudo Biosciences is a biopharmaceutical company.See details»
Sudo Biosciences - Craft
Sudo Biosciences has 5 employees at their 1 location and $153 m in total funding,. See insights on Sudo Biosciences including office locations, competitors, revenue, financials, executives, …See details»
Press Release | Sudo Biosciences
Oct 10, 2022 TYK2 is a key mediator in cytokine signaling pathways that have been linked to a broad range of immune-mediated inflammatory conditions. Sudo Biosciences is based in …See details»
Sudo Biosciences - PitchBook
Sudo Biosciences General Information Description. Operator of a biopharmaceutical company designed to develop novel medicines to transform patients' lives. The company's medicine …See details»
Sudo Biosciences - Products, Competitors, Financials, Employees ...
Headquarters Location. 10401 North Meridian Street Suite 225. Carmel, Indiana, 46290, United States. 317-660-1780See details»
Sudo Biosciences - VentureRadar
Similar Companies: Ventyx Biosciences USA Publicly Traded We are a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living …See details»
Sudo Biosciences | VentureRadar
Website: https://www.sudobio.com/ Develops novel medicines targeting the tyrosine kinase 2 pseudokinase domain to treat multiple sclerosis, neurodegenerative diseases ...See details»
Sudo Biosciences (USA) Funding: $183M - Medical Startups
Dec 19, 2024 Website: https://www.sudobio.com Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class …See details»
Leaps by Bayer
Approach. Sudo Biosciences is committed to designing and developing novel medicines to transform patients’ lives. The lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain.See details»
Press Release | Sudo Biosciences
For more information, visit www.sudobio.com. About Dementia Discovery Fund. The Dementia Discovery Fund (DDF), managed by SV Health Investors, is the world's largest family of …See details»
Press Release | Sudo Biosciences
Dec 2, 2024 Sudo Biosciences is based in Carmel, IN, with operations across the US and UK. For more information, visit www.sudobio.com. Media Contact. Kimberly Ha KKH Advisors 917 …See details»
Sudo Biosciences Raises $116M Series B Financing to ... - Enavate …
Dec 20, 2023 For more information, visit www.sudobio.com. About Enavate Sciences. Enavate Sciences is a portfolio company of Patient Square Capital dedicated to supporting therapeutic …See details»
Series B - Sudo Biosciences - 2024-02-13 - Crunchbase
Feb 13, 2024 Organization Name . Sudo Biosciences . Announced Date Feb 13, 2024; Closed On Date Feb 13, 2024; Funding Type Series B; Funding Stage Early Stage Venture; Money …See details»
Press Release | Sudo Biosciences
Sep 28, 2022 For more information, visit www.sudobio.com. About Frazier Life Sciences. Frazier Life Sciences invests globally in private and publicly-traded companies that discover, develop, …See details»
Latest News for Sudo Biosciences
Dec 20, 2023. Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the ClinicSee details»